Data as of November 21, 2026

Saxagliptin HCL 5 mg Tablet

SAXAGLIPTIN

Brand: Saxagliptin

Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.

Price per fill

NADAC (acquisition)
$45.18/ fill$1.07 / EA
Cost Plus Drugs (retail)
$25.54/ fill$0.60 / EA
FUL
$129.76/ fill$3.07 / EA
AMP
$74.15/ fill$1.75 / EA
Medicaid FFS
$244.78/ fill
Medicaid MCO
$169.59/ fill

Sources: cms/nadac:price-ladder · costplusdrugs/price-list · cms/ful:generic-ceiling · cms/sdud. Cost Plus prices as of 2026-11-21

What's in the reimbursement

Ingredient cost (42.3 units/fill)$45.18
Dispensing fee & other (state-fixed, not margin)$199.60
Total reimbursed per fill$244.78

The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.

Medicaid volume backing this card: 1 fee-for-service states, 3 managed-care states.

Full methodology and source columns: /tools/drug-prices/methodology

Sources: acquisition prices from CMS's National Average Drug Acquisition Cost survey, effective 2026-11-11; utilisation from CMS State Drug Utilization Data, 2024; Cost Plus Drugs prices from their published price list. NADAC and SDUD vintages differ. Every number links to how it was calculated. Full methodology